Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation

References

• Li Y, Wu YF, Chen KP, et al. Prevalence of atrial fibrillation in china and its risk factors. Biomed Environ Sci. 2013;26(9):709–716. doi:10.3967/0895-3988.2013.09.001
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988. doi:10.1161/01.str.22.8.983
   PubMed Web of Science ®Google Scholar
• Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus Warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093. doi:10.1056/NEJMoa1310907
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962. doi:10.1016/S0140-6736(13)62343-0
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857. doi:10.7326/0003-4819-146-12-200706190-00007
   PubMed Web of Science ®Google Scholar
• Olesen JB, Sorensen R, Hansen ML, et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: danish nationwide descriptive data 2011-2013. Europace. 2015;17(2):187–193. doi:10.1093/europace/euu225
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi:10.1093/eurheartj/ehw210
   PubMed Web of Science ®Google Scholar
• Deshpande CG, Kogut S, Laforge R, et al. Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants. Curr Med Res Opin. 2018;34(7):1285–1292. doi:10.1080/03007995.2018.1428543
   PubMed Web of Science ®Google Scholar
• Borne RT, O’Donnell C, Turakhia MP, et al. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration. BMC Cardiovasc Disord. 2017;17(1):236. doi:10.1186/s12872-017-0671-6
   PubMed Web of Science ®Google Scholar
• Laliberté F, Nelson WW, Lefebvre P, et al. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012;29(8):675–690. doi:10.1007/s12325-012-0040-x
   PubMed Web of Science ®Google Scholar
• Emren SV, Senoz O, Bilgin M, et al. Drug adherence in patients with nonvalvular atrial fibrillation taking non-Vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR.. Clin Appl Thrombosis/Hemostasis. 2018;24(3):525–531. doi:10.1177/1076029617693940
   Web of Science ®Google Scholar
• Fang SJ, Linzheng SG. Study on the relationship between warfarin anticoagulation compliance and self-efficacy in patients with non-valvular atrial fibrillation . Chin J Pract Nurs. 2010;(35):1–4. doi:10.3760/cma.j.issn.1672-7088.2010.12.040
   Google Scholar
• Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215. doi:10.1037//0033-295x.84.2.191
   PubMed Web of Science ®Google Scholar
• Dong XF, Liu YJ, Wang AX, et al. Psychometric properties of the Chinese version of the Self-Efficacy for Appropriate Medication Use Scale in patients with stroke. Patient Prefer Adherence. 2016;10:321–327. doi:10.3870/hlxzz.2015.11.047
   Web of Science ®Google Scholar
• Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007;15(3):203–219. doi:10.1891/106137407783095757
   PubMedGoogle Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Nakashima A, Nakamura Y, et al. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: an observational cross-sectional pilot study. PLoS One. 2018;13(9):e204814. doi:10.1371/journal.pone.0204814
   Web of Science ®Google Scholar
• Rossi AP, Facchinetti R, Ferrari E, et al. Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2018;46(2):139–144. doi:10.1007/s11239-018-1679-1
   PubMed Web of Science ®Google Scholar
• Qiao J, Bai YY, Ma JL, et al. Compliance of new oral anticoagulants in elderly patients with non-valvular atrial fibrillation: an analysis on influence factors. Chin J Evid Bases Cardiovasc Med. 2020;12(5):540–542. doi:10.3969/j.issn.1674-4055.2020.05.09
   Google Scholar
• Eysenbach G. What is e-health? . J Med Internet Res. 2001;3(2):e20. doi:10.2196/jmir.3.2.e20
   PubMed Web of Science ®Google Scholar
• Desteghe L, Vijgen J, Koopman P, et al. Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1394–1403. doi:10.1093/eurheartj/ehx762
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Y, Lane DA, et al. Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF App Trial. Am J Med. 2017;30(12):1388–1396. doi:10.1016/j.amjmed.2017.07.003
   Web of Science ®Google Scholar
• Zhao S, Zhao H, Wang X, et al. Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China[J. 2017;11:213–220. doi:10.2147/PPA.S120962
   Google Scholar
• Suzuki T, Shiga T, Omori H, et al. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. J Cardiol. 2017;70(3):238–243. doi:10.1016/j.jjcc.2016.11.009
   PubMed Web of Science ®Google Scholar
• Gorst-Rasmussen A, Skjoth F, Larsen TB, et al. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. J Thromb Haemost. 2015;13(4):495–504. doi:10.1111/jth.12845
   PubMed Web of Science ®Google Scholar
• Chen P, Wang T, Hsieh M, et al. Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study. BMJ Open. 2019;9(9):e29974. doi:10.1136/bmjopen-2019-029974
   Web of Science ®Google Scholar
• Polsook R, Aungsuroch Y, Thongvichean T. The effect of self-efficacy enhancement program on medication adherence among post-acute myocardial infarction. Appl Nurs Res. 2016;32:67–72. doi:10.1016/j.apnr.2016.05.002
   PubMed Web of Science ®Google Scholar
• Manzoor BS, Lee TA, Sharp LK, et al. Real-world adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation. Pharmacotherapy. 2017;37(10):1221–30. doi:10.1002/phar.1989
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ni W. Health care utilization and treatment persistence associated with oral paliperidone and lurasidone in schizophrenia treatment. J Manage Care Spec Pharm. 2015;21(9):780–792. doi:10.18553/jmcp.2015.21.9.780
   Web of Science ®Google Scholar
• Jiang Y, Weiyi N. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy. 2015;35(9):813–822. doi:10.1002/phar.1634
   PubMed Web of Science ®Google Scholar